# Michael Trauner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-trauner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 69,425 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 131 |
| i10-index | 704 |
| Last Known Institution | Medical University of Vienna |
| OpenAlex ID | https://openalex.org/A5084197662 |
| ORCID iD | https://orcid.org/0000-0002-1275-6425 |
| Works | 3,320 |

## Researcher papers

- [A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis](https://scholariq.org/papers/a-placebo-controlled-trial-of-obeticholic-acid-in-primary-biliary-cholangitis/)
- [Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis](https://scholariq.org/papers/patient-age-sex-and-inflammatory-bowel-disease-phenotype-associate-with-course/)
- [Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis](https://scholariq.org/papers/diagnostic-accuracy-of-non-invasive-tests-for-advanced-fibrosis-in-patients-with/)
- [Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials](https://scholariq.org/papers/selonsertib-for-patients-with-bridging-fibrosis-or-compensated-cirrhosis-due-to/)
- [FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2](https://scholariq.org/papers/fxr-inhibition-may-protect-from-sars-cov-2-infection-by-reducing-ace2/)
- [Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma](https://scholariq.org/papers/deviations-of-the-immune-cell-landscape-between-healthy-liver-and-hepatocellular/)
- [Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis](https://scholariq.org/papers/performance-of-non-invasive-tests-and-histology-for-the-prediction-of-clinical/)
- [Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group](https://scholariq.org/papers/systematic-review-of-response-criteria-and-endpoints-in-autoimmune-hepatitis-by/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Pediatric Hepatobiliary Diseases and Treatments](https://scholariq.org/topics/pediatric-hepatobiliary-diseases-and-treatments/)

## Researcher university

- [Medical University of Vienna](https://scholariq.org/institutions/medical-university-of-vienna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.